Stocks TelegraphStocks Telegraph
Stock Ideas

KRYS Financial Statements and Analysis

NASDAQ : KRYS

Krystal Biotech, Inc.

$161.30
2.27+1.43%
At Close 4:00 PM
$161.32
0.02+0.01%
Pre-Market 08:30 AM
69.18
BESG ScoreESG Rating

KRYS FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

KRYS Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q3Q2Q1
revenue83.841M70.284M42.143M8.556M0
cost of revenue6.684M7.995M4.378M223.00K1.20M
gross profit77.157M62.289M37.765M8.333M-1.20M
gross profit ratio0.920.8860.8960.9740
research and development expenses13.511M15.583M11.37M10.629M12.144M
general and administrative expenses00023.697M25.904M
selling and marketing expenses00000
selling general and administrative expenses28.713M25.64M23.257M23.697M25.904M
other expenses12.50M18.509M0223.00K0
operating expenses54.724M41.223M34.627M34.549M38.048M
cost and expenses61.408M49.218M39.005M34.549M38.048M
interest income07.479M7.519M6.74M4.838M
interest expense00000
depreciation and amortization1.529M1.986M1.507M826.00K1.038M
ebitda31.257M18.031M4.645M-25.993M-37.01M
ebitda ratio0.3730.3280.11-3.0380
operating income22.433M21.066M3.138M-25.993M-38.048M
operating income ratio0.2680.300.074-3.0380
total other income expenses net7.336M-5.021M7.519M106.74M4.838M
income before tax29.769M16.045M10.657M80.747M-33.21M
income before tax ratio0.3550.2280.2539.4370
income tax expense2.589M477.00K1.965M-826.00K0
net income27.18M15.568M8.692M80.747M-33.21M
net income ratio0.3240.2220.2069.4370
eps0.950.540.312.88-1.25
eps diluted0.910.530.302.79-1.25
weighted average shs out28.716M28.598M28.169M28.042M26.657M
weighted average shs out dil29.902M29.637M28.818M28.892M26.657M
Graph

KRYS Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302023-12-312023-06-302023-03-31
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q3Q2Q1
cash and cash equivalents373.966M345.786M358.328M373.241M275.875M
short term investments214.358M213.826M173.85M188.828M201.642M
cash and short term investments588.324M559.612M532.178M562.069M477.517M
net receivables97.298M103.236M42.04M9.316M0
inventory18.581M12.179M6.985M5.278M0
other current assets8.961M7.745M6.706M5.465M6.487M
total current assets713.164M682.772M587.909M582.128M484.004M
property plant equipment net163.063M165.468M168.229M171.389M171.327M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments105.888M69.292M61.954M36.548M28.41M
tax assets00000
other non current assets203.00K125.999K263.00K285.00K285.00K
total non current assets269.154M234.886M230.446M208.222M200.022M
other assets01.00000
total assets982.318M917.658M818.355M790.35M684.026M
account payables5.58M5.425M4.132M4.34M4.446M
short term debt1.292M2.722M1.474M1.501M1.529M
tax payables573.00K709.00K2.283M152.00K22.00K
deferred revenue001.0019.427M17.271M
other current liabilities82.082M62.995M27.488M2.315M652.00K
total current liabilities89.527M71.851M33.094M27.583M23.898M
long term debt6.184M6.326M6.62M6.819M7.014M
deferred revenue non current0-588.00K000
deferred tax liabilities non current00000
other non current liabilities761.00K588.00K-1.0000
total non current liabilities6.945M6.914M6.62M6.819M7.014M
other liabilities001.0000
capital lease obligations7.476M6.326M6.62M8.32M8.543M
total liabilities96.472M78.765M39.714M34.402M30.912M
preferred stock00000
common stock00000
retained earnings-226.147M-253.327M-269.827M-278.519M-359.266M
accumulated other comprehensive income loss1.512M-634.00K638.00K-382.00K-236.00K
other total stockholders equity1.11B1.093B1.048B1.035B1.013B
total stockholders equity885.846M838.893M778.641M755.948M653.114M
total equity885.846M838.893M778.641M755.948M653.114M
total liabilities and stockholders equity982.318M917.658M818.355M790.35M684.026M
minority interest00000
total investments320.246M283.118M235.804M225.376M230.052M
total debt1.292M7.687M8.094M8.32M8.543M
net debt-372.674M-338.099M-350.234M-364.921M-267.332M
Graph

KRYS Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302023-12-312023-06-302023-03-31
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q3Q2Q1
deferred income tax00-46.305M-100.00M0
stock based compensation13.316M13.156M9.853M8.312M11.331M
change in working capital26.992M-33.293M-25.711M-9.192M-11.583M
accounts receivables5.939M-56.769M-32.724M00
inventory-3.678M530.00K-492.00K00
accounts payables91.00K784.00K-222.00K-360.00K374.00K
other working capital-34.401M22.162M7.727M-8.832M-11.957M
other non cash items-10.195M70.998M44.732M-1.919M-1.766M
net cash provided by operating activities58.857M-4.168M-7.232M-21.226M-34.19M
investments in property plant and equipment-1.046M-1.131M-1.847M-1.781M-2.79M
acquisitions net00000
purchases of investments-112.532M-113.401M-82.906M-105.901M-174.393M
sales maturities of investments79.25M95.179M74.593M112.874M161.226M
other investing activites000100.00M0
net cash used for investing activites-34.328M-19.353M-10.16M105.192M-15.957M
debt repayment00000
common stock issued-26.607M10.638M2.619M13.388M185.269M
common stock repurchased00000
dividends paid00000
other financing activites29.972M10.638M000
net cash used provided by financing activities3.365M10.638M2.619M13.388M185.269M
effect of forex changes on cash286.00K-337.00K-140.00K12.00K8.00K
net change in cash28.18M-13.22M-14.913M97.366M135.13M
cash at end of period373.966M345.786M358.328M373.241M275.875M
cash at beginning of period345.786M359.006M373.241M275.875M140.745M
operating cashflow58.857M-4.168M-7.232M-21.226M-34.19M
capital expenditure-1.046M-1.131M-1.847M-1.781M-2.79M
free cash flow57.811M-5.299M-9.079M-23.007M-36.98M
Graph

Frequently Asked Questions

How did Krystal Biotech, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, KRYS generated $83.84M in revenue last quarter, while its costs came in at $6.68M.

Last quarter, how much Gross Profit did Krystal Biotech, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Krystal Biotech, Inc. reported a $77.16M Gross Profit for the quarter ended Sep 30, 2024.

Have KRYS's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. KRYS incurred $54.72M worth of Operating Expenses, while it generated $22.43M worth of Operating Income.

How much Net Income has KRYS posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Krystal Biotech, Inc., the company generated $27.18M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Krystal Biotech, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Krystal Biotech, Inc. as of the end of the last quarter was $373.97M.

What are KRYS's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, KRYS had Total Net Receivables of $97.30M.

In terms of Total Assets and Current Assets, where did Krystal Biotech, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of KRYS were $713.16M, while the Total Assets stand at $982.32M.

As of the last quarter, how much Total Debt did Krystal Biotech, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of KRYS's debt was $1.29M at the end of the last quarter.

What were KRYS's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, KRYS reported total liabilities of $96.47M.

How much did KRYS's Working Capital change over the last quarter?

Working Capital Change for KRYS was $26.99M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

KRYS generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. KRYS generated $58.86M of Cash from Operating Activities during its recently reported quarter.

What was KRYS's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. KRYS reported a $28.18M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph